| Ident. | Authors (with country if any) | Title |
|---|
| 000136 (2016) |
Suhan Senova ; Koichi Hosomi ; Jean-Marc Gurruchaga ; Gaëtane Gouello ; Naoufel Ouerchefani ; Yara Beaugendre ; Hélène Lepetit ; Jean-Pascal Lefaucheur ; Romina Aron Badin ; Julien Dauguet ; Caroline Jan ; Philippe Hantraye ; Pierre Brugières ; Stéphane Palfi | Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies. |
| 000473 (2015) |
Romina Aron Badin [France] ; Marta Vadori [Italie] ; Emanuele Cozzi [Italie] ; Philippe Hantraye [France] | Translational research for Parkinson׳s disease: The value of pre-clinical primate models. |
| 000941 (2014) |
Stéphane Palfi [France] ; Jean Marc Gurruchaga [France] ; G Scott Ralph [Royaume-Uni] ; Helene Lepetit [France] ; Sonia Lavisse [France] ; Philip C. Buttery [Royaume-Uni] ; Colin Watts [Royaume-Uni] ; James Miskin [Royaume-Uni] ; Michelle Kelleher [Royaume-Uni] ; Sarah Deeley [Royaume-Uni] ; Hirokazu Iwamuro [France] ; Jean Pascal Lefaucheur [France] ; Claire Thiriez [France] ; Gilles Fenelon [France] ; Cherry Lucas [Royaume-Uni] ; Pierre Brugières [France] ; Inanna Gabriel [France] ; Kou Abhay [France] ; Xavier Drouot [France] ; Naoki Tani [France] ; Aurelie Kas [France] ; Bijan Ghaleh [France] ; Philippe Le Corvoisier [France] ; Patrice Dolphin [France] ; David P. Breen [Royaume-Uni] ; Sarah Mason [Royaume-Uni] ; Natalie Valle Guzman [Royaume-Uni] ; Nicholas D. Mazarakis [Royaume-Uni] ; Pippa A. Radcliffe [Royaume-Uni] ; Richard Harrop [Royaume-Uni] ; Susan M. Kingsman [Royaume-Uni] ; Olivier Rascol [France] ; Stuart Naylor [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Pierre Cesaro [France] ; Kyriacos A. Mitrophanous [Royaume-Uni] | Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial. |
| 000972 (2014) |
Shane Grealish [Suède] ; Elsa Diguet [France] ; Agnete Kirkeby [Suède] ; Bengt Mattsson [Suède] ; Andreas Heuer [Suède] ; Yann Bramoulle [France] ; Nadja Van Camp [France] ; Anselme L. Perrier [France] ; Philippe Hantraye [France] ; Anders Björklund [Suède] ; Malin Parmar [Suède] | Human ESC-Derived Dopamine Neurons Show Similar Preclinical Efficacy and Potency to Fetal Neurons when Grafted in a Rat Model of Parkinson’s Disease |
| 000A21 (2014) |
Gurdal Sahin [Suède] ; Lachlan H. Thompson [Suède, Australie] ; Sonia Lavisse ; Merve Ozgur [Suède] ; Latifa Rbah-Vidal ; Frédéric Dollé ; Philippe Hantraye ; Deniz Kirik [Suède] | Differential Dopamine Receptor Occupancy Underlies L-DOPA-Induced Dyskinesia in a Rat Model of Parkinson's Disease |
| 000B29 (2014) |
Stéphane Palfi [France] ; Jean Marc Gurruchaga [France] ; G. Scott Ralph [Royaume-Uni] ; Helene Lepetit [France] ; Sonia Lavisse [France] ; Philip C. Buttery [Royaume-Uni] ; Colin Watts [Royaume-Uni] ; James Miskin [Royaume-Uni] ; Michelle Kelleher [Royaume-Uni] ; Sarah Deeley [Royaume-Uni] ; Hirokazu Iwamuro [France] ; Jean Pascal Lefaucheur [France] ; Claire Thiriez [France] ; Gilles Fenelon [France] ; Cherry Lucas [Royaume-Uni] ; Pierre Brugieres [France] ; Inanna Gabriel [France] ; Kou Abhay [France] ; Xavier Drouot [France] ; Naoki Tani [France] ; Aurelie Kas [France] ; Bijan Ghaleh [France] ; Philippe Le Corvoisier [France] ; Patrice Dolphin [France] ; David P. Breen [Royaume-Uni] ; Sarah Mason [Royaume-Uni] ; Natalie Valle Guzman [Royaume-Uni] ; Nicholas D. Mazarakis [Royaume-Uni] ; Pippa A. Radcliffe [Royaume-Uni] ; Richard Harrop [Royaume-Uni] ; Susan M. Kingsman [Royaume-Uni] ; Olivier Rascol [France] ; Stuart Naylor [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Pierre Cesaro [France] ; Kyriacos A. Mitrophanous [Royaume-Uni] | Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial |
| 000D29 (2013) |
Romina Aron Badin [France] ; Brigitte Spinnewyn [France] ; Marie-Claude Gaillard [France] ; Caroline Jan [France] ; Carole Malgorn [France] ; Nadja Van Camp [France] ; Frédéric Dollé [France] ; Martine Guillermier [France] ; Sabrina Boulet [France] ; Anne Bertrand [France] ; Marc Savasta [France] ; Michel Auguet [France] ; Emmanuel Brouillet [France] ; Pierre-Etienne Chabrier [France] ; Philippe Hantraye [France] | IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates |
| 001949 (2011) |
Masahiro Shin [France] ; Caroline Jan [France] ; Carine Jacquard [France] ; Bechir Jarraya [France] ; Jacques Callebert [France] ; Jean-Marie Launay [France] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Stephane Palfi [France] ; Emmanuel Brouillet [France] | Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration |
| 001C01 (2010) |
Sandro Alves [France] ; Isabel Nascimento-Ferreira ; Nolle Dufour [France] ; Raymonde Hassig [France] ; Gwennalle Auregan [France] ; Clvio Nbrega ; Emmanuel Brouillet [France] ; Philippe Hantraye [France] ; Maria C. Pedroso De Lima ; Nicole Dglon [France] ; Lus Pereira De Almeida [Portugal] | Silencing ataxin-3 mitigates degeneration in a rat model of MachadoJoseph disease: no role for wild-type ataxin-3? |
| 002093 (2009) |
Béchir Jarraya [France] ; Sabrina Boulet ; G Scott Ralph ; Caroline Jan ; Gilles Bonvento ; Mimoun Azzouz ; James E. Miskin ; Masahiro Shin ; Thierry Delzescaux ; Xavier Drouot ; Anne-Sophie Hérard ; Denise M. Day ; Emmanuel Brouillet ; Susan M. Kingsman ; Philippe Hantraye ; Kyriacos A. Mitrophanous ; Nicholas D. Mazarakis ; Stéphane Palfi | Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia. |
| 002097 (2009) |
Aurélie Kas [France] ; Michel Bottlaender ; Jean Dominique Gallezot ; Marie Vidailhet ; Gabriel Villafane ; Marie Claude Grégoire ; Christine Coulon ; Héric Valette ; Frédéric Dollé ; Maria-Joao Ribeiro ; Philippe Hantraye ; Philippe Remy | Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease. |
| 002368 (2009) |
Aurélie Kas [France] ; Michel Bottlaender [France] ; Jean Dominique Gallezot [France, États-Unis] ; Marie Vidailhet [France] ; Gabriel Villafane [France] ; Marie Claude Gregoire [France] ; Christine Coulon [France] ; Héric Valette [France] ; Frédéric Dolle [France] ; Maria-Joao Ribeiro [France] ; Philippe Hantraye [France] ; Philippe Remy [France] | Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease |
| 002479 (2008) |
Camille Brochier [France] ; Marie-Claude Gaillard ; Elsa Diguet ; Nicolas Caudy ; Carole Dossat ; Béatrice Ségurens ; Patrick Wincker ; Emmanuel Roze ; Jocelyne Caboche ; Philippe Hantraye ; Emmanuel Brouillet ; Jean-Marc Elalouf ; Michel De Chaldée | Quantitative gene expression profiling of mouse brain regions reveals differential transcripts conserved in human and affected in disease models. |
| 002535 (2008) |
Sandro Alves [Portugal, France] ; Isabel Nascimento-Ferreira [Portugal] ; Gwennaëlle Auregan [France] ; Raymonde Hassig [France] ; Noëlle Dufour [France] ; Emmanuel Brouillet [France] ; Maria C. Pedroso De Lima [Portugal] ; Philippe Hantraye [France] ; Luís Pereira De Almeida [Portugal] ; Nicole Déglon [France] | Allele-Specific RNA Silencing of Mutant Ataxin-3 Mediates Neuroprotection in a Rat Model of Machado-Joseph Disease |
| 002770 (2008) |
Cecilia Lundberg [Suède] ; Tomas Björklund [Suède] ; Thomas Carlsson [Suède] ; Johan Jakobsson [Suède] ; Philippe Hantraye [France] ; Nicole Deglon [France] ; Deniz Kirik [Suède] | Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders |
| 003250 (2004) |
Xavier Drouot [France] ; Satoru Oshino ; Bechir Jarraya ; Laurent Besret ; Haruhiko Kishima ; Philippe Remy ; Julien Dauguet ; Jean Pascal Lefaucheur ; Frédéric Dollé ; Françoise Condé ; Michel Bottlaender ; Marc Peschanski ; Yves Kéravel ; Philippe Hantraye ; Stéphane Palfi | Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation. |
| 003379 (2004) |
Philippe Remy [France] ; Stéphane Palfi [France] ; Philippe Hantraye [France] | Le suivi lésionnel et thérapeutique des maladies neurodégénératives par l'imagerie fonctionnelle |
| 003437 (2004) |
Marc Peschanski [France] ; Anne-Catherine Bachoud-Levi [France] ; Philippe Hantraye [France] | Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease |
| 003571 (2003) |
Valérie Cochen [France] ; Maria-Joao Ribeiro [France] ; Jean-Paul Nguyen [France] ; Jean-Marc Gurruchaga [France] ; Gabriel Villafane [France] ; Christian Loc'H [France] ; Gilles Defer [France] ; Yves Samson [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Philippe Remy [France] | Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue |
| 003697 (2003) |
Valérie Cochen [France] ; Maria-Joao Ribeiro [France] ; Jean-Paul Nguyen [France] ; Jean-Marc Gurruchaga [France] ; Gabriel Villafane [France] ; Christian Loc'H [France] ; Gilles Defer [France] ; Yves Samson [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Philippe Remy [France] | Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue |
| 003844 (2002) |
Maria-Joao Ribeiro [France] ; Marie Vidailhet ; Christian Loc'H ; Corinne Dupel ; Jean Paul Nguyen ; Michel Ponchant ; Frédéric Dollé ; Marc Peschanski ; Philippe Hantraye ; Pierre Cesaro ; Yves Samson ; Philippe Remy | Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease. |
